From: Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets
Breast Cancer Subtype | Fold-change | P-value | Patient numbers | Overexpression Gene Rank | Study Ref |
---|---|---|---|---|---|
Ductal Breast Carcinoma | 5.3 | 6.62E-18 | 40 | Top 1% | Richardson [33] |
Male Breast Carcinoma | 4.7 | 1.84E-31 | 3 | Top 1% | TCGA [31] |
Invasive Ductal Breast Carcinoma | 3.2 | 5.54E-47 | 389 | Top 1% | TCGA [31] |
Medullary Breast Carcinoma | 2.6 | 1.23E-8 | 32 | Top 7% | Curtis [28] |
Invasive Ductal Breast Carcinoma | 2.2 | 9.54E-81 | 1,556 | Top 3% | Curtis [28] |
Invasive Lobular Breast Carcinoma | 2.1 | 1.58E-11 | 36 | Top 4% | TCGA [31] |
Ductal Breast Carcinoma In Situ | 2.1 | 8.67E-6 | 11 | Top 1% | Ma [10] |
Breast Carcinoma | 2.1 | 4.00E-5 | 14 | Top 5% | Curtis [28] |
Invasive Breast Carcinoma | 2.1 | 1.99E-5 | 21 | Top 7% | Curtis [28] |